Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Central Garden & Pet (CENTA) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Central Garden & Pet (CENTA) over the last 16 years, with Q4 2025 value amounting to $721.2 million.

  • Central Garden & Pet's Cash & Equivalents rose 1668.72% to $721.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $721.2 million, marking a year-over-year increase of 1668.72%. This contributed to the annual value of $882.5 million for FY2025, which is 1711.07% up from last year.
  • Central Garden & Pet's Cash & Equivalents amounted to $721.2 million in Q4 2025, which was up 1668.72% from $882.5 million recorded in Q3 2025.
  • Over the past 5 years, Central Garden & Pet's Cash & Equivalents peaked at $882.5 million during Q3 2025, and registered a low of $39.9 million during Q1 2021.
  • For the 5-year period, Central Garden & Pet's Cash & Equivalents averaged around $404.8 million, with its median value being $383.9 million (2021).
  • As far as peak fluctuations go, Central Garden & Pet's Cash & Equivalents plummeted by 8797.51% in 2021, and later soared by 39719.01% in 2024.
  • Central Garden & Pet's Cash & Equivalents (Quarter) stood at $296.0 million in 2021, then crashed by 70.34% to $87.8 million in 2022, then soared by 288.86% to $341.4 million in 2023, then skyrocketed by 81.02% to $618.0 million in 2024, then rose by 16.69% to $721.2 million in 2025.
  • Its Cash & Equivalents was $721.2 million in Q4 2025, compared to $882.5 million in Q3 2025 and $713.0 million in Q2 2025.